Skip to main content

A League of our own in KILLING Bacteria to LOG8 in 10 Seconds with CONTINUOUS REMOVAL for 24 hours.

A LEAGUE OF OUR OWN IN KILLING BACTERIA

We have developed the range of exclusive products with all IP patent pending, owned by Sanare Health Limited.

Our team and partners area of special expertise is in combating the rise of antimicrobial resistance in pathogenic organisms.

Sanare Health are the owners of the IP working with industry leading partners to manufacture the clinical products and are looking to work in collaboration and provide under licence manufacture Worldwide to research & develop and then market newly patent pending blends.

SCIENTIFICALLY MORE EFFECTIVE EXCLUSIVE FORMULATION

These blends, based on advanced exclusive technologies, increase surface activity making them highly effective in the removal of bio-film and against antimicrobial bacteria thus giving them a great advantage in medical sector cleaning and disinfection.

We have the capability to research & develop new products and supply the new developed advanced products in sufficient quantity to support high volume trading on a global scale.

LICENSING SANARE TECHNOLOGY

We are currently looking for established partners.

Assisting product launch initiatives of our Healthcare, Dental , Veterinary and Equine partners, no matter whether it is UK or rest of the World.

Contact Us

MANUFACURING & COMMERCIAL PARTNERS

We are currently looking for established manufacturers to assist in the commercialisation of our initial product ranges.
We are willing to consider licensing the rights to manufacture in Europe, Middle East, Japan, India and other countries.

Contact Us

INVESTMENT OPPORTUNITIES

Investment funding will be available under the UK government’s Enterprise Investment Scheme (EIS), by offering tax reliefs to investors, including 30% income tax relief, tax-free capital gains on profits, loss relief, capital gains tax deferral, and inheritance tax relief.